Cross-fund · 5 holders
KROS
KEROS THERAPEUTICS INC
CUSIP 492327101
5
Tracked holders
$66.2M
Aggregate value
4,706,787
Shares
5
Active funds
Funds holding KROS
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $31.1M | — | −1,193,422 | −43.9% |
| BlackRock | Institutional | Q1 2026 | $26.6M | — | +121,261 | +5.3% |
| Citadel | Multi-Strategy | Q1 2026 | $6.1M | — | −144,354 | −20.7% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $1.2M | — | +70,167 | +180.6% |
| Millennium | Multi-Strategy | Q1 2026 | $1.2M | — | −113,351 | −51.5% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.